• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

Can Whole Exome Sequencing Explain Prenatal Loss With Insufficient Fetal DNA?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Whole exome sequencing (WES) can diagnose 25 to 37% of postnatal unexplained single gene disorders
    • The technique depends on obtaining good quality DNA from ‘trios’ – mother/father/affected child
  • In the prenatal setting, identification of lethal prenatal genetic disorders is not always possible using the ‘trio’ approach, due to either poor quality or insufficient quantity of fetal DNA
  • Stals et al. (Prenatal Diagnosis, 2017) have developed a novel technique to detect recessive single gene disorders using parental samples and saving fetal DNA where available for confirmation studies

METHODS:

  • WES sequencing was performed on couples (unaffected) with at least 1 fetus affected with severe, lethal, prenatal onset disease
    • Special filtering was applied to WES data
    • Fetal DNA was saved to confirm pathogenic variants
  • Potential pathogenic variants were identified using a bioinformatics pipeline that highlighted changes in disease-causing genes consistent with the clinical phenotype and autosomal recessive inheritance pattern
  • Disease-causing variants were confirmed using stored fetal DNA

RESULTS:

  • Exome sequencing was carried out in a consecutive series of 50 couples
  • WES identified heterozygous pathogenic (or likely pathogenic) variants in 24 different genes in 26/50 couples (52%)
  • A genetic diagnosis was obtained in 18/29 cases (62%) when 2 fetuses in a family were affected and in 8/21 (38%) when only 1 fetus was affected
  • In 25 cases, autosomal recessive inheritance was identified and in 1 case, an X-linked recessive disorder was identified
  • A diagnosis was made in 6/11 (54%) of couples who were consanguineous

CONCLUSION:

  • Exome sequencing of parental samples is a powerful strategy for diagnosing lethal or prenatal-onset recessive disorders and can be applied even in the absence of large, high quality fetal samples
  • The authors suggest various explanations for those cases that remained undiagnosed including
    • Disorder may not yet be associated with a known phenotype
    • Disorder may not be a monogenic (single gene), autosomal recessive disorder
  • Identifying pathogenic variants may provide useful information to parents considering PGD or prenatal diagnosis in subsequent pregnancies

Learn More – Primary Sources:

Diagnosis of lethal or prenatal-onset autosomal recessive disorders by parental exome sequencing

image_pdfFavoriteLoadingFavorite

< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

The Exome and Whole Exome Sequencing: Prenatal Testing Recommendations
The Genome and Whole Genome Sequencing
CRISPR Nobel Prize Technology: “A tool for rewriting the code of life”

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site